Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection

dc.authoridSayar, Merve Sefa/0000-0002-0436-4122
dc.authoridAcar, Ali/0000-0003-2008-5112
dc.authorscopusid57222508487
dc.authorscopusid57222439243
dc.authorscopusid55777973900
dc.authorwosidSayar, Merve Sefa/GVS-7640-2022
dc.authorwosidErdim, Dilek/JAC-3222-2023
dc.contributor.authorAcar, Ali
dc.contributor.authorBulut, Dilek
dc.contributor.authorAcar, Ali
dc.contributor.otherBasic Sciences
dc.date.accessioned2024-07-05T15:25:08Z
dc.date.available2024-07-05T15:25:08Z
dc.date.issued2023
dc.departmentAtılım Universityen_US
dc.department-temp[Sayar, Merve Sefa; Bulut, Dilek] Van Training & Res Hosp, Infect Dis & Clin Microbiol, Van, Turkiye; [Sayar, Merve Sefa] Bursa Yuksek Ihtisas Training & Res Hosp, Infect Dis & Clin Microbiol, Bursa, Turkiye; [Bulut, Dilek] Diskapi Yildirim Beyazit Training & Res Hosp, Infect Dis & Clin Microbiol, Ankara, Turkiye; [Acar, Ali] Atilim Univ, Dept Microbiol, Fac Med, Ankara, Turkiye; [Sayar, Merve Sefa] Van Egitim & Arastirma Hastanesi, Blok 2 kat Hastaliklari Poliklinigi Edremit, Van, Turkiyeen_US
dc.descriptionSayar, Merve Sefa/0000-0002-0436-4122; Acar, Ali/0000-0003-2008-5112en_US
dc.description.abstractBackground and study aims: The current study aimed to investigate the frequency of hepatic steatosis in chronic hepatitis B (CHB) patients and determine the possible risk factors associated with its presence.Patients and methods: This cross-sectional study retrospectively evaluated the medical records of 255 adult CHB patients visiting an infectious disease outpatient clinic. Patients with hepatitis B surface anti-gen positivity for >6 months and those who did not receive antiviral therapy were included in the study. The presence and stage of hepatic steatosis were determined through hepatobiliary ultrasonography.Results: The mean age of the patients was 40.6 +/- 12.7 years. Hepatic steatosis was detected in 44.4 % of the patients through ultrasound imaging. Our findings showed that the detected steatosis prevalence in our patients with CHB was significantly higher compared to the highest prevalence of non-alcoholic steatohepatitis found in the general Turkish population (19.9 %) [RR 2.23 (1.75-2.86), p < 0.001]. CHB patients with steatosis had significantly higher age, triglyceride, and gamma-glutamyl transferase levels than those without steatosis (p < 0.05). No significant association was found between the presence of steatosis, sex, liver function test results, and platelet, alkaline phosphatase, cholesterol, alpha fetoprotein, or HBV-DNA levels. No significant relationship was found between aspartate aminotransferase (AST)/platelet ratio index (APRI) and steatosis was examined (p > 0.05). Post-hoc analysis showed a sig-nificant relationship between HBV-DNA levels and ALT, AST, and APRI scores.Conclusion: Our data showed that hepatic steatosis is more common in CHB patients than in the general population. Older age and high triglyceride levels increased the risk of hepatic steatosis in CHB patients, consequently increasing GGT levels, which are indicative of liver damage, in these patients.(c) 2022 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.en_US
dc.identifier.citation2
dc.identifier.doi10.1016/j.ajg.2022.05.002
dc.identifier.endpage15en_US
dc.identifier.issn1687-1979
dc.identifier.issn2090-2387
dc.identifier.issue1en_US
dc.identifier.pmid35688683
dc.identifier.scopus2-s2.0-85132346772
dc.identifier.scopusqualityQ3
dc.identifier.startpage11en_US
dc.identifier.urihttps://doi.org/10.1016/j.ajg.2022.05.002
dc.identifier.urihttps://hdl.handle.net/20.500.14411/2511
dc.identifier.volume24en_US
dc.identifier.wosWOS:000953415500001
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAPRIen_US
dc.subjectChronic hepatitis Ben_US
dc.subjectFatty liveren_US
dc.subjectFibrosisen_US
dc.titleEvaluation of hepatosteatosis in patients with chronic hepatitis B virus infectionen_US
dc.typeArticleen_US
dspace.entity.typePublication
relation.isAuthorOfPublication3c0e93fc-6f64-486e-8d88-93d616e547ed
relation.isAuthorOfPublication.latestForDiscovery3c0e93fc-6f64-486e-8d88-93d616e547ed
relation.isOrgUnitOfPublicationc6d3b3b7-f103-4779-9789-92b2e2420f2d
relation.isOrgUnitOfPublication.latestForDiscoveryc6d3b3b7-f103-4779-9789-92b2e2420f2d

Files

Collections